Join the Oncology Voice Network. Join for Free
From Medically Impossible to Medical MIRACLE
Anthony Lee ZAP Mortgage overcoming odds business success peak performance

From Medically Impossible to Medical MIRACLE


Share This Article


Summary

Anthony Lee is the CEO of ZAP Mortgage, ex Military Special Forces and Best Selling author who tells his story of overcoming extreme odds to find unprecedented success in business and life.

Learn more about…

👉 What it takes to overcome severe set backs and extreme odds
👉 How your mental game can bring you to new levels of success
👉 What types of habits and behaviors will lead to personal and professional growth
👉 Advice for peak performance and career differentiation

Click for Source
Anthony Lee, ZAP Mortgage, overcoming odds, business success, peak performance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
The BURN: How to Become a TOP Performer & Excel at the HIGHEST Levels
Partner Avatar MSL Talk: Tom Caravela, Ben Newman

The BURN: How to Become a TOP Performer & Excel at the HIGHEST Levels

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Article
EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies
OVN Avatar Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma

EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for hematological malignancies

Article
Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals
OVN Avatar R. Kurzrock, L.A. Gurski, R.W. Carlson, D.S. Ettinger, S.M. Horwitz, S.K. Kumar, L. Million, M. von Mehren, A.B. Benson III

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals

Explore OVN